Cedar Mountain Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.41K | Hold |
1,000
| – | – | ﹤0.01% | 222 |
|
|
2025
Q1 | $5.42K | Hold |
1,000
| – | – | ﹤0.01% | 245 |
|
|
2024
Q4 | $7.45K | Hold |
1,000
| – | – | ﹤0.01% | 224 |
|
|
2024
Q3 | $7.99K | Hold |
1,000
| – | – | ﹤0.01% | 214 |
|
|
2024
Q2 | $8.7K | Hold |
1,000
| – | – | ﹤0.01% | 198 |
|
|
2024
Q1 | $20.7K | Hold |
1,000
| – | – | 0.01% | 135 |
|
|
2023
Q4 | $23.1K | Hold |
1,000
| – | – | 0.01% | 120 |
|
|
2023
Q3 | $7.99K | Hold |
1,000
| – | – | ﹤0.01% | 186 |
|
|
2023
Q2 | $8.7K | Hold |
1,000
| – | – | ﹤0.01% | 175 |
|
|
2023
Q1 | $2.94K | Hold |
1,000
| – | – | ﹤0.01% | 229 |
|
|
2022
Q4 | $3.5K | Hold |
1,000
| – | – | ﹤0.01% | 230 |
|
|
2022
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 175 |
|
|
2022
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 177 |
|
|
2022
Q1 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 157 |
|
|
2021
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 159 |
|
|
2021
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 164 |
|
|
2021
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 174 |
|
|
2021
Q1 | $10K | Sell |
1,000
-10,000
| -91% | -$100K | ﹤0.01% | 170 |
|
|
2020
Q4 | $72K | Buy |
11,000
+10,800
| +5,400% | +$70.7K | 0.03% | 57 |
|
|
2020
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 234 |
|
|
2020
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 217 |
|
|
2020
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 195 |
|
|
2019
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 195 |
|